The treatment of systemic sclerosis.
Black
C M
CM
Academic Unit of Rheumatology, Royal Free Hospital School of Medicine, London, United Kingdom.
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008171:Lung Diseases / Q000188:drug therapy / Q000209:etiology; D011928:Raynaud Disease / Q000188:drug therapy / Q000209:etiology; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000933:Antifibrinolytic Agents; D007166:Immunosuppressive Agents; D014665:Vasodilator Agents